Why the study?
METS-VF is considered a more effective measure for visceral adipose tissue than other obesity indicators, but its association with NAFLD across age groups in both sexes required evaluation.
Does the Metabolic Visceral Fat Score (METS-VF) accurately identify non-alcoholic fatty liver disease (NAFLD) compared to other visceral adipose tissue surrogate markers?
Does the Metabolic Visceral Fat Score (METS-VF) accurately identify non-alcoholic fatty liver disease (NAFLD) compared to other visceral adipose tissue surrogate markers?
METS-VF is a highly accurate surrogate marker for identifying NAFLD, with its diagnostic performance significantly influenced by age and sex.
No takes yet. Share an insight, caveat, or question.
METS-VF may aid NAFLD risk stratification in observational cohorts; leaves open prospective validation and incremental value by age/sex.
Kuang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: